Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Summit Therapeutics to Participate in Upcoming Investor Conferences

Posted on: 22 Nov 17

Summit Therapeutics plc

("Summit", or the "Company")


Oxford, UK, 9 February 2018 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug discovery and development company advancing therapies for rare diseases and infectious diseases, announces that management will participate in two upcoming investor conferences in New York City, US.

  • BIO CEO & Investor Conference - 12 February 2018, presentation at 3:15pm EST
  • SunTrust Robinson Humphrey 4th Annual Orphan Drug Day - 13 February 2018

A live audio webcast of the BIO CEO presentation will be available through the Investors section on the Company's website, A replay of the webcast will be available from the same location soon after the live presentation. For the SunTrust Robinson Humphrey Orphan Drug Day, the Company will participate in one on one meetings.

About Summit Therapeutics

Summit is a biopharmaceutical company focused on the discovery, development and commercialisation of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease, Duchenne muscular dystrophy, and the infectious disease, Clostridium difficile infection. Further information is available at and Summit can be followed on Twitter (@summitplc).

For more information, please contact:


Glyn Edwards / Richard Pye (UK office) Tel: 44 (0)1235 443 951
Erik Ostrowski / Michelle Avery (US office)   +1 617 225 4455
Cairn Financial Advisers LLP (Nominated Adviser) Tel: +44 (0)20 7213 0880
Liam Murray / Tony Rawlinson    
N+1 Singer (Joint Broker) Tel: +44 (0)20 7496 3000
Aubrey Powell / Jen Boorer    
Panmure Gordon (Joint Broker) Tel: +44 (0)20 7886 2500
Freddy Crossley / Duncan Monteith, Corporate Finance    
Tom Salvesen, Corporate Broking    
MacDougall Biomedical Communications (US) Tel: +1 781 235 3060
Karen Sharma
Consilium Strategic Communications (UK) Tel: +44 (0)20 3709 5700
Mary-Jane Elliott / Sue Stuart /
Jessica Hodgson / Philippa Gardner    




Last updated on: 12/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.